KEN TAKANASHI
CIK 1657768 · last filed 2026-03-26
KEN TAKANASHI is a corporate insider who has filed 19 SEC Form 4 insider transactions across 2 companies since 2015. The most recent filing, for WVE, was dated Mar 26, 2026. Across all open-market trades the lifetime net is +$27.5M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $56.5M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$56.53M
2
19
$27.53M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| WVE | Director | 9,630,351 | $5.87 | $56.53M | $3.96M | 13 | 2026-03-26 |
| Satsuma Pharmaceuticals, Inc. (STSA) Delisted | Director | 24,847,694 | $1.10 | $27.33M | $23.57M | 6 | 2023-06-08 |
Recent Filings
19 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-03-26 | WVE | Conv (C) | +3,901,348 | $0 | EDGAR |
| 2025-08-13 | WVE | Grant (A) | +12,700 | $0 | EDGAR |
| 2025-08-07 | WVE | Sell (S) | −4,872 | -$42.6K | EDGAR |
| 2024-08-14 | WVE | Grant (A) | +16,115 | $0 | EDGAR |
| 2023-08-09 | WVE | Grant (A) | — | $0 | EDGAR |
| 2023-06-08 | Satsuma Pharmaceuticals, Inc. (STSA) Delisted | Mixed | +22,053,581 | $20.07M | EDGAR |
| 2022-12-09 | Satsuma Pharmaceuticals, Inc. (STSA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-08-17 | WVE | Grant (A) | — | $0 | EDGAR |
| 2022-06-07 | Satsuma Pharmaceuticals, Inc. (STSA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-08-18 | WVE | Grant (A) | — | $0 | EDGAR |